Practical considerations for iron therapy in the management of anaemia in patients with chronic kidney disease

被引：14

作者：

Roger, Simon D. ^{[1
]}

机构：

[1] Gosford Hosp, Dept Renal Med, Gosford, NSW, Australia

来源：

CLINICAL KIDNEY JOURNAL | 2017年 / 10卷

关键词：

anaemia; CKD; ESRD; ESA; iron; ERYTHROPOIESIS-STIMULATING AGENTS; RANDOMIZED CONTROLLED-TRIAL; CHRONIC-RENAL-FAILURE; INTRAVENOUS IRON; ORAL IRON; HEMODIALYSIS-PATIENTS; DEFICIENCY ANEMIA; IV IRON; SERUM FERRITIN; SUCROSE;

D O I：

10.1093/ckj/sfx100

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Clinical practice guidelines provide both local and global recommendations for the use of iron therapy in the management of anaemia in patients with chronic kidney disease. However, physicians must interpret and adapt these guidelines to meet the specific needs of their individual patients. The recommendations must also be considered in the context of findings from more recently published clinical trials and observational studies.

引用

页码：9 / 15

页数：7

共 50 条

[41] NIMO-CKD-UK: a real-world, observational study of iron isomaltoside in patients with iron deficiency anaemia and chronic kidney disease [J].

Kalra, Philip A. ;

Bhandari, Sunil ;

Spyridon, Michael ;

Davison, Rachel ;

Lawman, Sarah ;

Mikhail, Ashraf ;

Reaich, David ;

Pritchard, Nick ;

McCafferty, Kieran ;

Moore, Jason .

BMC NEPHROLOGY, 2020, 21 (01)

[42] FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia [J].

Macdougall, Iain C. ;

Bock, Andreas H. ;

Carrera, Fernando ;

Eckardt, Kai-Uwe ;

Gaillard, Carlo ;

Van Wyck, David ;

Roubert, Bernard ;

Nolen, Jacqueline G. ;

Roger, Simon D. .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 (11) :2075-2084

[43] Novel iron-based phosphate binders in patients with chronic kidney disease [J].

Shah, Hitesh H. ;

Hazzan, Azzour D. ;

Fishbane, Steven .

CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2015, 24 (04) :330-335

[44] Safety aspects of parenteral iron supplementation therapies in patients with chronic kidney disease [J].

Potthoff, S. A. ;

Muench, H. G. .

DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2013, 138 (24) :1312-1317

[45] The problem with transferrin saturation as an indicator of iron 'sufficiency' in chronic kidney disease [J].

Besarab, Anatole ;

Drueke, Tilman B. .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36 (08) :1377-1383

[46] Non-erythropoietin-based anaemia management in chronic kidney disease [J].

Hörl, WH .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 :35-38

[47] Anaemia management in non-dialysis chronic kidney disease (CKD) patients: a multicentre prospective study in renal clinics [J].

Minutolo, Roberto ;

Locatelli, Francesco ;

Gallieni, Maurizio ;

Bonofiglio, Renzo ;

Fuiano, Giorgio ;

Oldrizzi, Lamberto ;

Conte, Giuseppe ;

De Nicola, Luca ;

Mangione, Filippo ;

Esposito, Pasquale ;

Dal Canton, Antonio .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 (12) :3035-3045

[48] Anaemia management in chronic kidney disease patients:: an overview of current clinical practice [J].

Valderrábano, F .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 :13-18

[49] Intravenous Iron Therapy and Risk for Progressive Loss of Kidney Function in Patients with Chronic Kidney Disease [J].

Mansour, Wissam ;

Bissram, Melisha ;

Rosner, Mitchell H. .

NEPHRON CLINICAL PRACTICE, 2011, 118 (02) :C189-C194

[50] Safety concerns about intravenous iron therapy in patients with chronic kidney disease [J].

Del Vecchio, Lucia ;

Longhi, Selena ;

Locatelli, Francesco .

CLINICAL KIDNEY JOURNAL, 2016, 9 (02) :260-267

← 1 2 3 4 5 →